(Q38084184)

28 August 2017

Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants (English)

1 reference

28 August 2017

1 reference

Yan-Jun Xu

1

1 reference

28 August 2017

Paramjit S Tappia

series ordinal

2

1 reference

28 August 2017

Nirankar S Neki

series ordinal

3

1 reference

28 August 2017

Naranjan S Dhalla

series ordinal

4

1 reference

28 August 2017

1 January 2014

1 reference

28 August 2017

Heart Failure Reviews

1 reference

28 August 2017

19

1 reference

28 August 2017

1

1 reference

28 August 2017

113-121

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-013-9379-6

28 August 2017

0 references

cites work

Congestive heart failure in the diabetic

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Cardiomyopathy associated with noninsulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Free radical biology of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Oxidative stress and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Role of oxidative stress in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Oxidative stress and redox regulation of phospholipase D in myocardial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Redox regulation of cardiomyocyte survival and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Redox regulation of signal transduction in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Anti-atherosclerotic molecules targeting oxidative stress and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Suppression of high lipid diet induced by atherosclerosis sarpogrelate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Heart failure: the frequent, forgotten, and often fatal complication of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Silymarin: a novel antioxidant with antiglycation and antiinflammatory properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Experimental therapies in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Why have antioxidants failed in clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol and health--a comprehensive review of human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Greater effectiveness of ε-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Targeting platelets for prevention and treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Clinical trials of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Resveratrol in cholesterol metabolism and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Carotenoids and vitamins C and E in the prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

The relationship between plasma alpha-tocopherol concentration and vitamin E intake in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9379-6

Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients

21 January 2018

1 reference

12 December 2020

Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment

1 reference

12 December 2020

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

1 reference

12 December 2020

Antioxidant vitamins and coronary heart disease

1 reference

12 December 2020

Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study

1 reference

12 December 2020

The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism

1 reference

12 December 2020

Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy

1 reference

12 December 2020

N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.

1 reference

12 December 2020

Subcellular remodeling and heart dysfunction in chronic diabetes

1 reference

12 December 2020

Pomegranate phytosterol (β-sitosterol) and polyphenolic antioxidant (punicalagin) addition to statin, significantly protected against macrophage foam cells formation

1 reference

12 December 2020

Experimental evidence for the cardioprotective effects of red wine.

1 reference

12 December 2020

Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.

1 reference

12 December 2020

Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.

1 reference

12 December 2020

Cardioprotective interventions for cancer patients receiving anthracyclines

1 reference

12 December 2020

Resveratrol causes antiatherogenic effects in an animal model of atherosclerosis

1 reference

12 December 2020

SIRT1: new avenues of discovery for disorders of oxidative stress

1 reference

12 December 2020

Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes

1 reference

12 December 2020

Cytoprotective agents for anthracyclines

1 reference

12 December 2020

Response of blood platelets to resveratrol during a model of hyperhomocysteinemia

1 reference

12 December 2020

Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes

1 reference

12 December 2020

Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells

1 reference

12 December 2020

Pathogenesis of cardiac dysfunction in diabetes mellitus

1 reference

12 December 2020

Daily vitamin E supplementation does not improve metabolic and glycemic control in type 2 diabetic patients: a double blinded randomized controlled trial

1 reference

12 December 2020

Role of oxidative stress in alterations of mitochondrial function in ischemic-reperfused hearts

1 reference

12 December 2020

Potential role of lysophosphatidic acid in hypertension and atherosclerosis.

1 reference

12 December 2020

10.1007/S10741-013-9379-6

Identifiers

DOI

1 reference

28 August 2017

1 reference